Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin for proteinuria in non-diabetic glomerulonephritis
IRCT20251112067964N1Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of empagliflozin in Glomerulonephritis (GN) and proteinuria, sponsored by Babol University of Medical Sciences. Started Dec 2025; status: completed.
02
Drugs
empagliflozin
03
Conditions
Glomerulonephritis (GN)proteinuria
Beyond the preview
Go deeper on IRCT20251112067964N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251112067964N1.